Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Metabolic Syndrome
NCT02153983Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- May 2014
- Primary completion
- Aug 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in metabolic syndrome, obesity, type 2 diabetes mellitus (T2DM), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started May 2014; status: completed.
02
Drugs
colchicine
03
Conditions
metabolic syndromeobesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02153983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153983.